Template:Stent thrombosis: Difference between revisions

	Coronary stent thrombosis Microchapters
Home
Introduction
Definition
Epidemiology and Demographics
Relation to Bare Metal Stents
Relation to Drug Eluting Stents
Relation to Antiplatelet Medications
Pathophysiology
Risk Factors
Relationship to Discontinuation of Antiplatelet Therapy
Treatment
Complications
Prevention
Stent thrombosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Stent thrombosis
CDC onStent thrombosis
Stent thrombosis in the news
Blogs on Stent thrombosis
to Hospitals Treating Stent thrombosis
Risk calculators and risk factors for Stent thrombosis

@@ Line 40: / Line 40: @@
 |- bgcolor="Pink"
 !
-:[[Stent thrombosis incidence in drug eluting stents|Relation to Drug Eluting Stents]]
+:[[Stent thrombosis Relation to drug eluting stents|Relation to Drug Eluting Stents]]
-|-
-!
-|- bgcolor="Pink"
-!
-:[[Stent thrombosis incidence in drug eluting stents#Sirolimus eluting stent(SES) vs paclitaxel eluting stent(PES)|Sirolimus Eluting Stent vs Paclitaxel Eluting Stent]]
 |-
 !
@@ Line 82: / Line 76: @@
 |- bgcolor="PaleTurquoise"
 !
-[[Stent thrombosis prognosis|Prognosis]]
+[[Stent thrombosis complications|Complications]]
 |-
 !

Latest revision as of 16:07, 5 March 2013